\-\ Texto\\:\\ \ \(0\)\
\-\ pe\\:\\ normal\ \(0\)\
\-\ labs\\:tsh\\ of\\ 0\\.643\\ uiu\\/ml\ \(0\)\
\-\ ultrasound\\:\\ 1\\.\\ \\ large\\ heterogeneous\\ solid\\/cystic\\ nodule\\ with\\ multiple\\ internal\\ septations\\ and\\ echoes\\ located\\ at\\ the\\ lower\\ pole\\ of\\ the\\ left\\ thyroid\\ gland\\.\\ \\ second\\,\\ smaller\\ and\\ more\\ homogeneous\\ hypoechoic\\ nodule\\ is\\ seen\\ more\\ posteriorly\ \(0\)\
\-\ within\\ the\\ left\\ lower\\ pole\\.\\ \\ recommend\\ further\\ workup\\ with\\ thyroid\\ uptake\\ and\\ scan\\ and\\ consideration\\ of\\ biopsy\\ to\\ exclude\\ the\\ possibility\\ of\\ malignancy\ \(0\)\
\-\ agent\\:\\ \\ \\ i\\-131\\ \\ \\ \\ \\ \\ \\ \\ \\ \\ dose\\:\\ \\ 7\\.49\\ uci\ \(0\)\
\-\ agent\\:\\ \\ \\ tc99m\\ \\ \\ \\ \\ \\ \\ \\ \\ \\ dose\\:\\ \\ 9\\.91\\ mci\ \(0\)\
\-\ procedure\\:\\ \\ \\ \\ 24\\ hours\\ following\\ radiotracer\\ ingestion\\,\\ the\\ radioactive\\ iodine\\ uptake\\ \\(24\\ raiu\\)\\ was\\ determined\\.\\ \\ following\\ pertechnetate\\ injection\ \(0\)\
\-\ planar\\ and\\ pinhole\\ images\\ were\\ obtained\\ of\\ the\\ neck\\ from\\ the\\ anterior\\ and\\ anterior\\ oblique\\ projections\\.\\ \\ acquisition\\ time\\ were\\ determined\\ and\ \(0\)\
\-\ scintillation\\ images\\ were\\ reviewed\\ and\\ physical\\ exam\\ was\\ performed\\ to\\ collaborate\\ findings\\.\\ no\\ previous\\ studies\\ available\\ for\\ review\\.\ \(0\)\
\-\ findings\\:\\ \\ \\ \\ the\\ 24\\ hour\\ raiu\\ was\\ equal\\ to\\ 5\\.5\\%\\,\\ normal\\ is\\ 8\\ \\-\\ 30\\%\\.\ \(0\)\
\-\ acquisition\\ times\\ for\\ pinhole\\ images\\ range\\ from\\ 283\\ seconds\\ to\\ 420\\ seconds\\,\ \(0\)\
\-\ \\(normal\\ is\\ 150\\ \\-\\ 200\\ seconds\\)\\.\ \(1\)\
\-\ the\\ planar\\ pinhole\\ images\\ showed\\ a\\ normally\\ sized\\ gland\\ with\\ regular\\ contour\\ and\\ the\\ thyroid\\ gland\\ lying\\ within\\ the\\ thyroid\\ bed\\ with\\ generally\\ decreased\\ trapping\\ throughout\\.\\ \\ however\\,\\ there\\ was\\ an\\ area\\ of\\ questionably\\,\\ slightly\\ increased\\ uptake\\ within\\ the\ \(0\)\
\-\ right\\ lower\\ pole\\ medially\\ which\\ most\\ likely\\ is\\ due\\ to\\ slight\\ rotation\\ of\\ the\\ patient\\.\ \(1\)\
\-\ physical\\ exam\\ shows\\ a\\ non\\-tender\\ noamally\\-sized\\ thyroid\\ gland\\ with\\ no\\ palpable\\ nodules\\,\\ and\\ most\\ recent\\ thyroid\\ function\\ tests\\ for\\ this\\ patient\\ were\\ performed\\ on\\ 16apr02\\ demonstrating\\ a\\ tsh\\ of\\ 0\\.643\\ uiu\\/ml\\.\ \(0\)\
\-\ impression\\:\ \(2\)\
\-\ 1\\.\\ \\ \\ low\\ 24\\ hour\\ radioactive\\ iodine\\ uptake\\ of\\ 5\\.5\\%\\.\ \(0\)\
\-\ 2\\.\\ \\ \\ scintigraphic\\ exam\\ with\\ no\\ evidence\\ of\\ hot\\ or\\ cold\\ nodules\\.\ \(0\)\
\-\ thyroid\\ nodules\\ of\\ undetermined\\ significance\\.\ \(0\)\
\-\ euthyroidism\\ with\\ multinodular\\ gland\ \(0\)\
\-\ significant\\ exogenous\\ iodine\\ intake\ \(0\)\
\-\ pt\\ found\\ to\\ have\\ thyroid\\ nodules\\ on\\ carotid\\ ultrasound\\,\\ then\\ was\\ followed\\ up\\ with\\ dedicated\\ thyroid\\ ultrasound\\.\\ \\ patient\\ denies\\ any\\ thyroid\\-related\\ symptoms\ \(0\)\
\-\ in\\ our\\ asymptomatic\\ patient\\ with\\ a\\ normal\\ \\(i\\.e\\.\\ low\\-normal\\)\\ tsh\\ the\\ concern\\ was\\ to\\ differentiate\\ the\\ thyroid\\ nodules\\ seen\\ on\\ the\\ prior\\ ultrasound\\,\\ in\\ order\\ to\\ determine\\ if\\ the\\ nodules\\ were\\ hyperfunctioning\\ \\‚\\Ä\\úhot\\‚\\Ä\\ù\\,\\ hypofunctioning\\ \\‚\\Ä\\úcold\\‚\\Ä\\ù\\,\\ or\\ intermediate\\ \\‚\\Ä\\úwarm\\‚\\Ä\\ù\\.\\ \\ thyroid\\ malignancy\\ makes\\ up\\ \\.1\\%\\ of\\ all\\ cancers\\;\\ but\\ up\\ to\\ 4\\-7\\%\\ of\\ the\\ population\\ may\\ have\\ palpable\\ nodules\\ on\\ physical\\ exam\\ and\\ up\\ to\\ 40\\%\\ have\\ nodules\\ seen\\ on\\ ultrasound\\ or\\ other\\ imaging\\.\\ \\ if\\ a\\ single\\ cold\\ nodule\\ is\\ found\\ on\\ thyroid\\ scintigraphy\\,\\ the\\ risk\\ of\\ cancer\\ is\\ 5\\ to\\ 40\\%\\.\\ \\ less\\ than\\ 1\\%\\ of\\ hot\\ nodules\\ are\\ cancerous\\.\\ \\ our\\ patient\\ demonstrated\\ a\\ very\\ low\\ uptake\\ of\\ i131\\ with\\ a\\ low\\/normal\\ tsh\\.\\ \\ the\\ patient\\ denied\\ taking\\ any\\ medication\\ which\\ might\\ affect\\ thyroid\\ function\\ such\\ as\\ synthroid\\,\\ ptu\\,\\ or\\ lugol\\‚\\Ä\\ôs\\ solution\\.\\ \\ on\\ further\\ questioning\\,\\ the\\ patient\\ admitted\\ to\\ a\\ ct\\ of\\ the\\ chest\\,\\ abdomen\\ and\\ pelvis\\ three\\ weeks\\ previously\\ in\\ which\\ he\\ stated\\ that\\ contrast\\ was\\ injected\\ into\\ his\\ arm\\.\\ \\ ct\\ contrast\\ is\\ iodinated\\ and\\ will\\ concentrate\\ in\\ the\\ thyroid\\ gland\\.\\ \\ based\\ on\\ this\\ information\\,\\ it\\ was\\ concluded\\ that\\ the\\ iodinated\\ contrast\\ blocked\\ uptake\\ of\\ the\\ i131\\ and\\ resulted\\ in\\ a\\ flawed\\ study\\.\\ \\ had\\ this\\ information\\ been\\ placed\\ in\\ the\\ patient\\‚\\Ä\\ôs\\ history\\,\\ we\\ would\\ have\\ waited\\ a\\ number\\ of\\ months\\ to\\ perform\\ the\\ scan\\.\ \(0\)\
\-\ it\\ would\\ have\\ been\\ reasonable\\ to\\ simply\\ perform\\ a\\ fine\\ needle\\ aspiration\\ \\(fna\\)\\ with\\ ultrasound\\ guidance\\,\\ instead\\ of\\ first\\ performing\\ a\\ scan\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ thyroid\\:\\ 0\\.07934041137369896\ \(0\)\
\-\ nodules\\:\\ 0\\.05159008056411774\ \(0\)\
\-\ gland\\:\\ 0\\.0353336766154628\ \(0\)\
\-\ uptake\\:\\ 0\\.03296100412324478\ \(0\)\
\-\ pinhole\\:\\ 0\\.032127640032185815\ \(0\)\
\-\ tsh\\:\\ 0\\.03003968384511884\ \(0\)\
\-\ seconds\\:\\ 0\\.029647903994486833\ \(0\)\
\-\ 0\\.643\\:\\ 0\\.028529185838079285\ \(0\)\
\-\ hot\\:\\ 0\\.027788718303923213\ \(0\)\
\-\ iodine\\:\\ 0\\.02612393795864734\ \(0\)\
\-\ \\%\\:\\ 0\\.025803508522278418\ \(0\)\
\-\ cold\\:\\ 0\\.025009498921538115\ \(0\)\
\-\ ultrasound\\:\\ 0\\.024612840631129156\ \(0\)\
\-\ i131\\:\\ 0\\.022231741990003835\ \(0\)\
\-\ 24\\:\\ 0\\.021504575926381553\ \(0\)\
\-\ iodinated\\:\\ 0\\.021418426688123878\ \(0\)\
\-\ acquisition\\:\\ 0\\.021077454145541918\ \(0\)\
\-\ uiu\\/ml\\:\\ 0\\.01976526932965789\ \(0\)\
\-\ radioactive\\:\\ 0\\.019360210614596383\ \(0\)\
\-\ pole\\:\\ 0\\.019316682121432137\ \(0\)\
\-\ raiu\\:\\ 0\\.01900025710291281\ \(0\)\
\-\ 5\\.5\\:\\ 0\\.018834259386448244\ \(0\)\
\-\ \\:\\:\\ 0\\.018289236504703318\ \(0\)\
\-\ planar\\:\\ 0\\.017985184096909437\ \(0\)\
\-\ agent\\:\\ 0\\.017745352471816488\ \(0\)\
\-\ nodule\\:\\ 0\\.017098124268165076\ \(0\)\
\-\ perform\\:\\ 0\\.015868917212098228\ \(0\)\
\-\ were\\:\\ 0\\.01569810952014499\ \(0\)\
\-\ \\‚\\Ä\\ú\\:\\ 0\\.01549272290184058\ \(0\)\
\-\ \\‚\\Ä\\ù\\:\\ 0\\.01540588035450672\ \(0\)\
\-\ hour\\:\\ 0\\.015120982840048433\ \(0\)\
\-\ information\\:\\ 0\\.015070017283517237\ \(0\)\
\-\ have\\:\\ 0\\.01497118186379524\ \(0\)\
\-\ up\\:\\ 0\\.014872797094202094\ \(0\)\
\-\ dose\\:\\ 0\\.014471563113633703\ \(0\)\
\-\ determined\\:\\ 0\\.014429804521931737\ \(0\)\
\-\ 7\\.49\\:\\ 0\\.014264592919039643\ \(0\)\
\-\ 9\\.91\\:\\ 0\\.014264592919039643\ \(0\)\
\-\ collaborate\\:\\ 0\\.014264592919039643\ \(0\)\
\-\ 283\\:\\ 0\\.014264592919039643\ \(0\)\
\-\ noamally\\-sized\\:\\ 0\\.014264592919039643\ \(0\)\
\-\ 16apr02\\:\\ 0\\.014264592919039643\ \(0\)\
\-\ \\-euthyroidism\\:\\ 0\\.014264592919039643\ \(0\)\
\-\ thyroid\\-related\\:\\ 0\\.014264592919039643\ \(0\)\
\-\ low\\-normal\\:\\ 0\\.014264592919039643\ \(0\)\
\-\ 4\\-7\\:\\ 0\\.014264592919039643\ \(0\)\
\-\ low\\/normal\\:\\ 0\\.014264592919039643\ \(0\)\
\-\ our\\:\\ 0\\.013145398811845094\ \(0\)\
\-\ solid\\/cystic\\:\\ 0\\.013142995539492804\ \(0\)\
\-\ 420\\:\\ 0\\.013142995539492804\ \(0\)\
\-\ \\-significant\\:\\ 0\\.013142995539492804\ \(0\)\
\-\ ptu\\:\\ 0\\.013142995539492804\ \(0\)\
\-\ lugol\\:\\ 0\\.013142995539492804\ \(0\)\
\-\ flawed\\:\\ 0\\.013142995539492804\ \(0\)\
\-\ waited\\:\\ 0\\.013142995539492804\ \(0\)\
\-\ was\\:\\ 0\\.01279323653351051\ \(0\)\
\-\ questionably\\:\\ 0\\.01248690313155079\ \(0\)\
\-\ hyperfunctioning\\:\\ 0\\.01248690313155079\ \(0\)\
\-\ hypofunctioning\\:\\ 0\\.01248690313155079\ \(0\)\
\-\ exam\\:\\ 0\\.012150381488346526\ \(0\)\
\-\ function\\:\\ 0\\.011723500236492842\ \(0\)\
\-\ scintillation\\:\\ 0\\.011660324452317796\ \(0\)\
\-\ undetermined\\:\\ 0\\.011660324452317796\ \(0\)\
\-\ cancerous\\:\\ 0\\.011660324452317796\ \(0\)\
\-\ concentrate\\:\\ 0\\.011660324452317796\ \(0\)\
\-\ 40\\:\\ 0\\.01163483041711383\ \(0\)\
\-\ scan\\:\\ 0\\.01161296825452902\ \(0\)\
\-\ patient\\:\\ 0\\.011088568685001786\ \(0\)\
\-\ exogenous\\:\\ 0\\.01089980078039913\ \(0\)\
\-\ blocked\\:\\ 0\\.01089980078039913\ \(0\)\
\-\ uci\\:\\ 0\\.010709213344061939\ \(0\)\
\-\ malignancy\\:\\ 0\\.010686374361817203\ \(0\)\
\-\ images\\:\\ 0\\.010610122277989346\ \(0\)\
\-\ \\.1\\:\\ 0\\.010538727072770959\ \(0\)\
\-\ solution\\:\\ 0\\.010384503480854576\ \(0\)\
\-\ synthroid\\:\\ 0\\.010243708372457116\ \(0\)\
\-\ physical\\:\\ 0\\.010177210046510865\ \(0\)\
\-\ questioning\\:\\ 0\\.010114189428001555\ \(0\)\
\-\ pertechnetate\\:\\ 0\\.00999427361545508\ \(0\)\
\-\ tc99m\\:\\ 0\\.009882634664828945\ \(0\)\
\-\ dedicated\\:\\ 0\\.009882634664828945\ \(0\)\
\-\ concluded\\:\\ 0\\.009882634664828945\ \(0\)\
\-\ would\\:\\ 0\\.00984131675864754\ \(0\)\
\-\ palpable\\:\\ 0\\.009801362597410325\ \(0\)\
\-\ 150\\:\\ 0\\.009778203400852293\ \(0\)\
\-\ multinodular\\:\\ 0\\.009778203400852293\ \(0\)\
\-\ simply\\:\\ 0\\.009778203400852293\ \(0\)\
\-\ to\\:\\ 0\\.009674682068287714\ \(0\)\
\-\ i\\-131\\:\\ 0\\.009587615964515104\ \(0\)\
\-\ 200\\:\\ 0\\.009500128551456405\ \(0\)\
\-\ on\\:\\ 0\\.009370757441623665\ \(0\)\
\-\ fna\\:\\ 0\\.009338181207513067\ \(0\)\
\-\ lower\\:\\ 0\\.009329427521183799\ \(0\)\
\-\ contrast\\:\\ 0\\.00928531886799954\ \(0\)\
\-\ projections\\:\\ 0\\.00926290610130774\ \(0\)\
\-\ echoes\\:\\ 0\\.009190977682908332\ \(0\)\
\-\ recommend\\:\\ 0\\.009190977682908332\ \(0\)\
\-\ reviewed\\:\\ 0\\.009190977682908332\ \(0\)\
\-\ reasonable\\:\\ 0\\.00912211099291028\ \(0\)\
\-\ mci\\:\\ 0\\.008992592048454718\ \(0\)\
\-\ trapping\\:\\ 0\\.008992592048454718\ \(0\)\
\-\ scintigraphic\\:\\ 0\\.00893152355657309\ \(0\)\
\-\ guidance\\:\\ 0\\.008872676235908244\ \(0\)\
\-\ significance\\:\\ 0\\.00881589416501622\ \(0\)\
\-\ warm\\:\\ 0\\.00881589416501622\ \(0\)\
\-\ performing\\:\\ 0\\.00881589416501622\ \(0\)\
\-\ further\\:\\ 0\\.008794317611004071\ \(0\)\
\-\ found\\:\\ 0\\.008715293250654085\ \(0\)\
\-\ any\\:\\ 0\\.008708203990525222\ \(0\)\
\-\ instead\\:\\ 0\\.008707979319549114\ \(0\)\
\-\ normal\\:\\ 0\\.008670630774104215\ \(0\)\
\-\ 1\\.\\:\\ 0\\.008638152641739808\ \(0\)\
\-\ injected\\:\\ 0\\.008558507927751355\ \(0\)\
\-\ intake\\:\\ 0\\.008511602528280073\ \(0\)\
\-\ septations\\:\\ 0\\.008466018584968267\ \(0\)\
\-\ ingestion\\:\\ 0\\.008421683675278761\ \(0\)\
\-\ cancers\\:\\ 0\\.008336499640512706\ \(0\)\
\-\ \\,\\:\\ 0\\.008322801367036343\ \(0\)\
\-\ sized\\:\\ 0\\.008295532313677285\ \(0\)\
\-\ \\‚\\Ä\\ô\\:\\ 0\\.008265458704354226\ \(0\)\
\-\ seen\\:\\ 0\\.008197221432367428\ \(0\)\
\-\ differentiate\\:\\ 0\\.008141308721760901\ \(0\)\
\-\ bed\\:\\ 0\\.008034580618537929\ \(0\)\
\-\ scintigraphy\\:\\ 0\\.008034580618537929\ \(0\)\
\-\ intermediate\\:\\ 0\\.007967149070964194\ \(0\)\
\-\ affect\\:\\ 0\\.007967149070964194\ \(0\)\
\-\ fine\\:\\ 0\\.007967149070964194\ \(0\)\
\-\ s\\:\\ 0\\.007931286948590898\ \(0\)\
\-\ within\\:\\ 0\\.007913259264010104\ \(0\)\
\-\ medially\\:\\ 0\\.007870994668907881\ \(0\)\
\-\ following\\:\\ 0\\.00784879532977718\ \(0\)\
\-\ might\\:\\ 0\\.00784017234694883\ \(0\)\
\-\ resulted\\:\\ 0\\.007809926177026252\ \(0\)\
\-\ lying\\:\\ 0\\.0077802350141327305\ \(0\)\
\-\ which\\:\\ 0\\.007743420326420138\ \(0\)\
\-\ consideration\\:\\ 0\\.007722438763967554\ \(0\)\
\-\ performed\\:\\ 0\\.007710609486172554\ \(0\)\
\-\ a\\:\\ 0\\.007700967025603907\ \(0\)\
\-\ low\\:\\ 0\\.007689864248758575\ \(0\)\
\-\ makes\\:\\ 0\\.007666635890065985\ \(0\)\
\-\ stated\\:\\ 0\\.007535008641758619\ \(0\)\
\-\ been\\:\\ 0\\.007523608056517771\ \(0\)\
\-\ if\\:\\ 0\\.00750402405754251\ \(0\)\
\-\ impression\\:\\ 0\\.007390005148733235\ \(0\)\
\-\ i\\.e\\:\\ 0\\.007390005148733235\ \(0\)\
\-\ exclude\\:\\ 0\\.007344421205421429\ \(0\)\
\-\ taking\\:\\ 0\\.007344421205421429\ \(0\)\
\-\ non\\-tender\\:\\ 0\\.0073221019139451575\ \(0\)\
\-\ we\\:\\ 0\\.007278366198107101\ \(0\)\
\-\ equal\\:\\ 0\\.0072357815568168515\ \(0\)\
\-\ tests\\:\\ 0\\.0072357815568168515\ \(0\)\
\-\ population\\:\\ 0\\.007214902260965868\ \(0\)\
\-\ anterior\\:\\ 0\\.007122306873018568\ \(0\)\
\-\ workup\\:\\ 0\\.007114365398333172\ \(0\)\
\-\ needle\\:\\ 0\\.007038204377527371\ \(0\)\
\-\ determine\\:\\ 0\\.007001427272223882\ \(0\)\
\-\ possibility\\:\\ 0\\.006983347497793258\ \(0\)\
\-\ medication\\:\\ 0\\.006965467503963833\ \(0\)\
\-\ order\\:\\ 0\\.006930289532060262\ \(0\)\
\-\ more\\:\\ 0\\.006916428185476267\ \(0\)\
\-\ number\\:\\ 0\\.00689586008473456\ \(0\)\
\-\ concern\\:\\ 0\\.0068789162338166055\ \(0\)\
\-\ normally\\:\\ 0\\.006812861226502276\ \(0\)\
\-\ denied\\:\\ 0\\.0067339127407912225\ \(0\)\
\-\ smaller\\:\\ 0\\.0067033812127906016\ \(0\)\
\-\ times\\:\\ 0\\.0067033812127906016\ \(0\)\
\-\ contour\\:\\ 0\\.0067033812127906016\ \(0\)\
\-\ rotation\\:\\ 0\\.00664399388778991\ \(0\)\
\-\ homogeneous\\:\\ 0\\.006545038510519148\ \(0\)\
\-\ posteriorly\\:\\ 0\\.006531383383260468\ \(0\)\
\-\ aspiration\\:\\ 0\\.006517842526188435\ \(0\)\
\-\ slight\\:\\ 0\\.00650441404266951\ \(0\)\
\-\ or\\:\\ 0\\.006482347889732735\ \(0\)\
\-\ radiotracer\\:\\ 0\\.006451787518874106\ \(0\)\
\-\ injection\\:\\ 0\\.006451787518874106\ \(0\)\
\-\ oblique\\:\\ 0\\.006426102487876873\ \(0\)\
\-\ most\\:\\ 0\\.006384579746692803\ \(0\)\
\-\ regular\\:\\ 0\\.0063759241112707876\ \(0\)\
\-\ is\\:\\ 0\\.006368989399179741\ \(0\)\
\-\ hypoechoic\\:\\ 0\\.006303458734851737\ \(0\)\
\-\ generally\\:\\ 0\\.0062228238258745915\ \(0\)\
\-\ it\\:\\ 0\\.0062163378140227075\ \(0\)\
\-\ pe\\:\\ 0\\.006211625698294376\ \(0\)\
\-\ carotid\\:\\ 0\\.006200504534398321\ \(0\)\
\-\ the\\:\\ 0\\.0060400172928768555\ \(0\)\
\-\ demonstrating\\:\\ 0\\.00600254522664388\ \(0\)\
\-\ review\\:\\ 0\\.005992768018786335\ \(0\)\
\-\ admitted\\:\\ 0\\.005973389068872555\ \(0\)\
\-\ \\-\\:\\ 0\\.005927923814590174\ \(0\)\
\-\ findings\\:\\ 0\\.005886203675695662\ \(0\)\
\-\ denies\\:\\ 0\\.005835003674959672\ \(0\)\
\-\ previously\\:\\ 0\\.005808692152513426\ \(0\)\
\-\ procedure\\:\\ 0\\.005791385859444254\ \(0\)\
\-\ arm\\:\\ 0\\.005791385859444254\ \(0\)\
\-\ located\\:\\ 0\\.00569126384695544\ \(0\)\
\-\ single\\:\\ 0\\.005604628301764453\ \(0\)\
\-\ placed\\:\\ 0\\.005596977587855155\ \(0\)\
\-\ slightly\\:\\ 0\\.005589362877438629\ \(0\)\
\-\ range\\:\\ 0\\.0055667314179325775\ \(0\)\
\-\ hours\\:\\ 0\\.0054372124734770174\ \(0\)\
\-\ previous\\:\\ 0\\.005369498703354849\ \(0\)\
\-\ 30\\:\\ 0\\.005317296660930542\ \(0\)\
\-\ second\\:\\ 0\\.005310888244723266\ \(0\)\
\-\ based\\:\\ 0\\.005272961751241037\ \(0\)\
\-\ throughout\\:\\ 0\\.005175966547410885\ \(0\)\
\-\ 8\\:\\ 0\\.005170093136325806\ \(0\)\
\-\ studies\\:\\ 0\\.005164240967280194\ \(0\)\
\-\ pt\\:\\ 0\\.00514104167416303\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.0050844581825161906\ \(0\)\
\-\ pelvis\\:\\ 0\\.00502441975176639\ \(0\)\
\-\ very\\:\\ 0\\.005019070580027717\ \(0\)\
\-\ risk\\:\\ 0\\.005008424995726677\ \(0\)\
\-\ then\\:\\ 0\\.00492065837932377\ \(0\)\
\-\ obtained\\:\\ 0\\.004915640939714955\ \(0\)\
\-\ biopsy\\:\\ 0\\.004905652494557865\ \(0\)\
\-\ labs\\:\\ 0\\.004809019428697635\ \(0\)\
\-\ that\\:\\ 0\\.004776636662002664\ \(0\)\
\-\ less\\:\\ 0\\.0046827508160561205\ \(0\)\
\-\ \\(\\:\\ 0\\.004675480428762852\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.004674097731385255\ \(0\)\
\-\ this\\:\\ 0\\.004665714627738509\ \(0\)\
\-\ three\\:\\ 0\\.004661204252988528\ \(0\)\
\-\ available\\:\\ 0\\.004648412700388021\ \(0\)\
\-\ recent\\:\\ 0\\.004648412700388021\ \(0\)\
\-\ first\\:\\ 0\\.004639940832986816\ \(0\)\
\-\ internal\\:\\ 0\\.004635721474722932\ \(0\)\
\-\ followed\\:\\ 0\\.004635721474722932\ \(0\)\
\-\ \\)\\:\\ 0\\.004618366939244693\ \(0\)\
\-\ study\\:\\ 0\\.004549565302362394\ \(0\)\
\-\ cancer\\:\\ 0\\.00454557486143166\ \(0\)\
\-\ showed\\:\\ 0\\.004533662245831224\ \(0\)\
\-\ 2\\.\\:\\ 0\\.004397158805502036\ \(0\)\
\-\ area\\:\\ 0\\.004371903307660627\ \(0\)\
\-\ will\\:\\ 0\\.004326021065338418\ \(0\)\
\-\ such\\:\\ 0\\.00432254496738002\ \(0\)\
\-\ no\\:\\ 0\\.004176913352931078\ \(0\)\
\-\ decreased\\:\\ 0\\.004111256315088284\ \(0\)\
\-\ from\\:\\ 0\\.004098497453573503\ \(0\)\
\-\ abdomen\\:\\ 0\\.004096091040284299\ \(0\)\
\-\ in\\:\\ 0\\.0040912352440801445\ \(0\)\
\-\ and\\:\\ 0\\.004077873916263849\ \(0\)\
\-\ neck\\:\\ 0\\.004060263975758063\ \(0\)\
\-\ demonstrated\\:\\ 0\\.0040573138874708215\ \(0\)\
\-\ 5\\:\\ 0\\.004045567026608679\ \(0\)\
\-\ his\\:\\ 0\\.003985257326289534\ \(0\)\
\-\ weeks\\:\\ 0\\.00392439766488859\ \(0\)\
\-\ all\\:\\ 0\\.003910879432736717\ \(0\)\
\-\ time\\:\\ 0\\.003905503603947108\ \(0\)\
\-\ likely\\:\\ 0\\.0039001455759476644\ \(0\)\
\-\ ct\\:\\ 0\\.003868296612919233\ \(0\)\
\-\ he\\:\\ 0\\.003857908320441779\ \(0\)\
\-\ however\\:\\ 0\\.0038501101223253568\ \(0\)\
\-\ shows\\:\\ 0\\.003801575565904335\ \(0\)\
\-\ months\\:\\ 0\\.0037766040367153194\ \(0\)\
\-\ of\\:\\ 0\\.003770349540387975\ \(0\)\
\-\ due\\:\\ 0\\.0036897688559107437\ \(0\)\
\-\ evidence\\:\\ 0\\.003625311623571\ \(0\)\
\-\ than\\:\\ 0\\.0036230563995441325\ \(0\)\
\-\ prior\\:\\ 0\\.003550344291589585\ \(0\)\
\-\ for\\:\\ 0\\.003539359944867549\ \(0\)\
\-\ symptoms\\:\\ 0\\.00344604769724618\ \(0\)\
\-\ increased\\:\\ 0\\.003382661459222744\ \(0\)\
\-\ chest\\:\\ 0\\.0033086229774393506\ \(0\)\
\-\ 1\\:\\ 0\\.0032901721164396553\ \(0\)\
\-\ into\\:\\ 0\\.0032901721164396553\ \(0\)\
\-\ \\;\\:\\ 0\\.0032773805638391484\ \(0\)\
\-\ imaging\\:\\ 0\\.00323960165769515\ \(0\)\
\-\ other\\:\\ 0\\.003187117392722409\ \(0\)\
\-\ left\\:\\ 0\\.003094191809944708\ \(0\)\
\-\ may\\:\\ 0\\.0030328938008060257\ \(0\)\
\-\ large\\:\\ 0\\.003023531443092362\ \(0\)\
\-\ had\\:\\ 0\\.002983575759289172\ \(0\)\
\-\ but\\:\\ 0\\.0029490344676918086\ \(0\)\
\-\ multiple\\:\\ 0\\.002912307448995581\ \(0\)\
\-\ as\\:\\ 0\\.0020915493622882327\ \(0\)\
\-\ with\\:\\ 0\\.0020825986035417268\ \(0\)\
\-\ there\\:\\ 0\\.0020577921625647066\ \(0\)\
\-\ an\\:\\ 0\\.001912079068421893\ \(0\)\
\-\ history\\:\\ 0\\.0019097322616619472\ \(0\)\
\-\ are\\:\\ 0\\.0018849091788504884\ \(0\)\
\-\ at\\:\\ 0\\.0018734031599217363\ \(0\)\
\-\ \\.\\:\\ 0\\.0015509506061947402\ \(0\)\
\-\ right\\:\\ 0\\.001458950985615561\ \(0\)\
